| Identification | Back Directory | [Name]
Benzenesulfonamide, 4-[4-[[3-[(1E)-3-(2-bromophenyl)-3-oxo-1-propen-1-yl]-1H-indol-1-yl]methyl]-1H-1,2,3-triazol-1-yl]- | [CAS]
2417232-24-5 | [Synonyms]
hCAXII-IN-3
Benzenesulfonamide, 4-[4-[[3-[(1E)-3-(2-bromophenyl)-3-oxo-1-propen-1-yl]-1H-indol-1-yl]methyl]-1H-1,2,3-triazol-1-yl]- | [Molecular Formula]
C26H20BrN5O3S | [MOL File]
2417232-24-5.mol | [Molecular Weight]
562.44 |
| Hazard Information | Back Directory | [Uses]
hCAXII-IN-3 (Compound 6o) is a selective human carbonic anhydrase XII (hCAXII) inhibitor with a Ki of 10.0 nM[1]. | [References]
[1] Singh P, et al. Synthesis and carbonic anhydrase inhibition studies of sulfonamide based indole-1,2,3-triazole chalcone hybrids. Bioorg Chem. 2020 Jun;99:103839. DOI:10.1016/j.bioorg.2020.103839 |
|
|